Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Akebia Therapeutics (AKBA) Shares Issued (2016 - 2025)

Historic Shares Issued for Akebia Therapeutics (AKBA) over the last 10 years, with Q2 2025 value amounting to $1.5 million.

  • Akebia Therapeutics' Shares Issued changed N/A to $1.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $88.5 million, marking a year-over-year increase of 22761.78%. This contributed to the annual value of $42.5 million for FY2024, which is 53349.73% up from last year.
  • As of Q2 2025, Akebia Therapeutics' Shares Issued stood at $1.5 million.
  • In the past 5 years, Akebia Therapeutics' Shares Issued ranged from a high of $72.4 million in Q4 2021 and a low of -$1000.0 during Q4 2022
  • In the last 5 years, Akebia Therapeutics' Shares Issued had a median value of $6.5 million in 2022 and averaged $17.4 million.
  • In the last 5 years, Akebia Therapeutics' Shares Issued crashed by 10000.14% in 2022 and then skyrocketed by 66250000.0% in 2023.
  • Over the past 5 years, Akebia Therapeutics' Shares Issued (Quarter) stood at $72.4 million in 2021, then plummeted by 100.0% to -$1000.0 in 2022, then soared by 662500.0% to $6.6 million in 2023, then soared by 233.53% to $22.1 million in 2024, then plummeted by 93.02% to $1.5 million in 2025.
  • Its Shares Issued was $1.5 million in Q2 2025, compared to $64.9 million in Q1 2025 and $22.1 million in Q4 2024.